Jaiswal Sanjeet Kumar, Sarathi Vijaya, Malhotra Gaurav, Verma Priyanka, Hira Priya, Badhe Padma, Memon Saba Samad, Barnabas Rohit, Patil Virendra A, Lila R, Shah Nalini S, Bandgar Tushar
Department of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Department of Endocrinology, Vydehi institute of medical sciences and research center, Bengaluru, Karnataka, Mumbai, Maharashtra, India.
Indian J Endocrinol Metab. 2021 Sep-Oct;25(5):410-417. doi: 10.4103/ijem.ijem_307_21. Epub 2022 Jan 12.
Pheochromocytoma and paraganglioma (PGL), together called PPGL, are rare tumors with a limited number of studies on the diagnostic performance of Ga-DOTA (0)-Tyr (3)-octreotate positron emission tomography-computed tomography (Ga-DOTATATE PET/CT) from the Asian-Indian subcontinent.
In this retrospective study, PPGL suspects ( = 87) who had undergone at least contrast-enhanced computed tomography (CECT) and Ga-DOTATATE PET/CT, were included. Lesion-wise, patient-wise, and region-wise sensitivities of Ga-DOTATATE PET/CT, F fluorodeoxyglucose positron emission tomography CT (F-FDG PET/CT, = 53), I-metaiodobenzylguanidine (I-MIBG, = 37), and CECT were compared, and diagnostic performance of Ga-DOTATATE PET/CT in the detection of PPGL was calculated.
Ga-DOTATATE PET/CT had significantly higher lesion-wise sensitivity than I-MIBG for both primary (94% vs 75%, = 0.004) and metastatic disease (85% vs 59%, = 0.001) and higher sensitivity than CECT for metastatic lesions (83% vs 43%, = 0.0001). The lesion-wise sensitivity of Ga-DOTATATE PET/CT was similar to F-FDG PET/CT for both primary tumors (94% vs 85%, = 0.08) and metastatic lesions (82% vs 84%, = 0.76) in the whole cohort but tended to be inferior in the head to head comparison.
Ga-DOTATATE PET/CT had higher sensitivity for detection of PPGL than I-MIBG (primary and metastatic) and CECT (metastatic) but similar to F-FDG PET/CT (primary and metastatic).
嗜铬细胞瘤和副神经节瘤(PGL)统称为PPGL,是罕见肿瘤,来自亚洲-印度次大陆的关于镓-多胺基多乙酸(0)-酪氨酸(3)-奥曲肽正电子发射断层扫描-计算机断层扫描(镓-多胺基多乙酸奥曲肽PET/CT)诊断性能的研究数量有限。
在这项回顾性研究中,纳入了至少接受过对比增强计算机断层扫描(CECT)和镓-多胺基多乙酸奥曲肽PET/CT的PPGL疑似患者(n = 87)。按病变、患者和区域比较镓-多胺基多乙酸奥曲肽PET/CT、18F-氟脱氧葡萄糖正电子发射断层扫描CT(18F-FDG PET/CT,n = 53)、131I-间碘苄胍(131I-MIBG,n = 37)和CECT的敏感性,并计算镓-多胺基多乙酸奥曲肽PET/CT在检测PPGL中的诊断性能。
对于原发性疾病(94%对75%,P = 0.004)和转移性疾病(85%对59%,P = 0.001),镓-多胺基多乙酸奥曲肽PET/CT的病变敏感性显著高于131I-MIBG,对于转移性病变,其敏感性高于CECT(83%对43%,P = 0.0001)。在整个队列中,对于原发性肿瘤(94%对85%,P = 0.08)和转移性病变(82%对84%,P = 0.76),镓-多胺基多乙酸奥曲肽PET/CT的病变敏感性与18F-FDG PET/CT相似,但在直接比较中往往较低。
镓-多胺基多乙酸奥曲肽PET/CT在检测PPGL方面比131I-MIBG(原发性和转移性)和CECT(转移性)具有更高的敏感性,但与18F-FDG PET/CT(原发性和转移性)相似。